Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165152 · ClinicalTrials.gov registry record · NA
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT00165152 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 150 participants.
The verdict
NCT00165152, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
To evaluate two different ways of providing information about genetic testing for BRCA1 and BRCA2 alterations. The two forms of counseling are genetic counseling and enhanced informed consent which cover similar material but are organized differently.
Interventions
- PROCEDURE Genetic Counseling
- PROCEDURE Informed Consent Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 1998-07 |
| Est. Completion | 2005-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00165152
The ClinicalTrials.gov registry entry for NCT00165152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Genetic Counseling is the first listed.
NCT00165152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00165152 about?
NCT00165152 is a clinical study titled "Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing". To evaluate two different ways of providing information about genetic testing for BRCA1 and BRCA2 alterations. The two forms of counseling are genetic counseling and enhanced informed consent which cover similar material but are organized differently.
What is the current status of trial NCT00165152?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 1998-07. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00165152?
The interventions under investigation include: Genetic Counseling (PROCEDURE), Informed Consent Counseling (PROCEDURE).
Who is sponsoring clinical trial NCT00165152?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.